Resapp just reported its second CE Mark for its smartphone App following there first success just a few weeks ago.
No delays, no second, third meetings. All done thru BSI.
We we have waited 5 years. All we got were please provide another costly study with 20 patients. We did this and provided 42 patients and still got rejected.
Millions of dollars spent on clinical studies, meetings etc etc. Poster presentations at medical conferences. Still no details on any meeting with BSI or COC. Almost 2 months passed since our latest revised submission. Not a word from BSI.
5 years of shareholder pain and suffering. Not to mention the patients.
CE Mark Odds, page-136
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $27.18M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.6¢ | $117.2K | 18.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 537051 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 16284536 | 17 |
View Market Depth
| Last trade - 15.10pm 16/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |